We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Molecular Mechanism Involved in Early Stages of Apoptosis Characterized

A scientist working on a computer in a lab.
ISIS Scientist and lead author, Dr Luke Clifton operating the advanced Offspec instrument at the ISIS Neutron and Muon Centre in Oxfordshire that produced real time images of processes taking place inside cells for the study. Credit: STFC, ISIS Neutron and Muon Source.
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 2 minutes

The study, published today (2 June) in Science Advances, was led by Dr Luke Clifton at the Science and Technology Facilities Council (STFC) ISIS Neutron and Muon Source (ISIS) in Oxfordshire. They worked alongside partners at the University of Umea and European Spallation Source in Sweden.

It is the most recent in a series of research collaborations by this team, investigating the cellular proteins responsible for apoptosis.

A balance between life and death

Apoptosis is essential for human life, and its disruption can cause cancerous cells to grow and not respond to cancer treatment. It is regulated by two proteins with opposing roles known as Bax and Bcl-2.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

In normal cells, the soluble Bax protein is responsible for the clearance of old or diseased cells, and when activated, it perforates the cell mitochondrial membrane to form pores that trigger cell death.

This can be offset by Bcl-2, which is embedded within the mitochondrial membrane, where it acts to prevent untimely cell death by capturing and sequestering Bax proteins.

In cancerous cells however, the survival protein Bcl-2 is overproduced, leading to uninhibited cell proliferation.

While this process has long since been understood to be essential to cancer development, the precise role that Bax and the mitochondrial membrane play has been unclear until now.

Crucial new insights

The team used a technique known as neutron reflectometry (conducted using the advanced ISIS Surf and Offspec instruments) which enabled them to study in real time how BAX interacts with lipids in the mitochondrial membrane.

This showed that when Bax creates pores in the membrane, it extracts lipids to form clusters on the mitochondrial surface via a two-stage process:

  1. Fast adsorption of Bax on the mitochondrial membrane surface.
  2. Simultaneous formation of membrane-destroying pores and Bax-lipid clusters.

This is the first time that scientists have found direct evidence of the involvement of mitochondrial lipids during membrane perturbing in cell-death initiated by Bax.

The finding builds on previous studies by the team on the molecular mechanism of membrane-bound Bcl-2 to inform a full understanding of the early stages of apoptosis.

Solving our greatest health challenges

Dr Luke Clifton, STFC ISIS scientist and lead author, explains:

This work has relevance not only to our understanding of fundamental mammalian cell processes but to our understanding of cancer cells.

In order to develop effective cancer treatments, we need to characterise every step of the process by which cancerous cells spread so that we can identify opportunities to intervene in this process.

This research has provided another piece of the jigsaw and has moved us one step closer to tackling cancer before it takes hold.

It also really shows the capabilities of neutron reflectometry in structural studies on membrane biochemistry.

Professor Gerhard Gröbner, University of Umeå and co-lead author says:

The unique findings here will not only have a significant impact in the field of apoptosis research but will also open gateways for exploring Bax and its relatives as interesting targets in cancer therapy such as by tuning up their cell-killing potential.

Looking to the future

Continued research is already planned at ISIS to probe this mechanism further.

It is hoped that this will yield new insights into potential targets for pharmaceuticals such as the newly characterised Bax-lipid clusters which could provide a new focus for medical research.

Reference: Clifton LA, Wacklin-Knecht HP, Ådén J, Mushtaq AU, Sparrman T, Gröbner G. Creation of distinctive Bax-lipid complexes at mitochondrial membrane surfaces drives pore formation to initiate apoptosis. Sci Adv. 2023;9(22):eadg7940. doi: 10.1126/sciadv.adg7940

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.